Such mutations are found in a wide variety of human tumors and are particularly common in lower-grade gliomas, with 70%–80% of patients with grade II and III astrocytomas and oligodendrogliomas harboring IDH1 mutations (Yan et al. 2009). The gene discussed is IDH1; the disease is glioma.